Anti-androgen therapy in triple-negative breast cancer

Anti-androgen therapy in triple-negative breast cancer

Bibliographic Details
Main Authors:	Valerie N. Barton, Michael A. Gordon, Jennifer K. Richer, Anthony Elias
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758834016646735

Similar Items

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
by: Maša Brumec, et al.
Published: (2021-04-01)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
by: Yuka Asano, et al.
Published: (2017-01-01)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
by: Mina A, et al.
Published: (2017-09-01)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
by: Corey Speers, et al.
Published: (2017-08-01)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
by: Kristine Astvatsaturyan, et al.
Published: (2018-01-01)

Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple–negative breast cancer?
by: Ana Tečić-Vuger, et al.
Published: (2020-01-01)

Prognostic Value of Androgen Receptor in Triple Negative Breast Cancer of Iranian Patients in Yazd Region
by: Fatemeh Alsadat Nobakht, et al.
Published: (2020-11-01)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
by: Sindhu Govindan, et al.
Published: (2020-08-01)

Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
by: Fatma Zakaria, et al.
Published: (2016-06-01)

Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
by: Aiyu Zhu, et al.
Published: (2016-03-01)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
by: Shristi Bhattarai, et al.
Published: (2019-07-01)

Combining carbon monoxide-releasing molecules with anti-VEGF therapy for triple-negative breast cancer therapy
by: Kourti, Malamati
Published: (2018)

Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
by: Li Zhang, et al.
Published: (2015-01-01)

Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
by: Nalo Hamilton, et al.
Published: (2017-11-01)

Neoadjuvant Therapy in Operable Breast Cancer: Application to Triple Negative Breast Cancer
by: Foluso O. Ademuyiwa, et al.
Published: (2013-01-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
by: Parvin F. Peddi, et al.
Published: (2012-01-01)

Triple-negative breast cancer: new perspectives for targeted therapies
by: Tomao F, et al.
Published: (2015-01-01)

Simvastatin induced ferroptosis for triple-negative breast cancer therapy
by: Xianxian Yao, et al.
Published: (2021-10-01)

Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
by: Hanane Mansouri, et al.
Published: (2020-05-01)

Knock-out transmembrane prostate androgen-induced protein gene suppressed triple-negative breast cancer cell proliferation
by: Bantari W.K. Wardhani, et al.
Published: (2017-11-01)

Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.
by: Ramesh Narayanan, et al.
Published: (2014-01-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-05-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-04-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
by: Wei Song, et al.
Published: (2017-06-01)

Advanced triple negative breast cancer in pregnancy
by: Ahmedy, F., et al.
Published: (2020)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
by: Fleisher B, et al.
Published: (2016-10-01)

A review of current progress in triple-negative breast cancer therapy
by: Shen Meiying, et al.
Published: (2020-11-01)

Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
by: Alyssa Vito, et al.
Published: (2021-05-01)

A new immunochemical strategy for triple-negative breast cancer therapy
by: Chih-Wei Lin, et al.
Published: (2021-07-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI
by: Amna Ameer, et al.
Published: (2021-02-01)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01)

Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models
by: Maryam Nakhjavani, et al.
Published: (2019-08-01)

Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
by: Jack J. Chan, et al.
Published: (2019-10-01)

Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.
by: Pierluigi Gasparini, et al.
Published: (2014-01-01)